Imtiaz Chaudhry, MD
Retina Specialist · Bensalem, PANPI 1750550091
Payments from drug & device makers
Across 160 payments — averaging $31.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$1K
- Alimera Sciences, Inc.$723
- AbbVie$499
- Alcon$442
- Sun Pharmaceutical Industries Inc.$342
- Astellas Pharma US Inc$228
- plus $1K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $1,426 |
| Alimera Sciences, Inc. | 37 | $723 |
| AbbVie(2 entities) | 19 | $499 |
| Alcon | 11 | $442 |
| Sun Pharmaceutical Industries Inc. | 15 | $342 |
| Astellas Pharma US Inc | 5 | $228 |
| ANI Pharmaceuticals, Inc. | 13 | $185 |
| Glaukos Corporation | 4 | $144 |
| Oyster Point Pharma, Inc. | 4 | $104 |
| Amgen(2 entities) | 4 | $95 |
| Aerie Pharmaceuticals, Inc. | 3 | $77 |
| Dompe US, Inc. | 2 | $73 |
| Kala Pharmaceuticals, Inc. | 3 | $66 |
| Genentech USA, Inc. | 3 | $65 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $64 |
| Harrow Eye, LLC | 3 | $59 |
| Sight Sciences, Inc. | 3 | $56 |
| AstraZeneca | 2 | $47 |
| Mallinckrodt Hospital Products Inc. | 2 | $44 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $41 |
| Coherus Oncology, Inc. | 1 | $40 |
| Boston Scientific | 1 | $29 |
| Bausch & Lomb Americas Inc. | 2 | $29 |
| Coloplast | 1 | $27 |
| Sandoz | 1 | $25 |
| Dutch Ophthalmic, USA | 1 | $23 |
| Rayner Intraocular Lenses Limited | 1 | $22 |
| Eyepoint US, Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Ocular Therapeutix, Inc. | 1 | $15 |
How this compares
$5,024 in reported general payments places this provider in the 65th percentile of 43 retina specialist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other retina specialist in Bensalem
- Albert MaguirePhiladelphia$4.1M
- Joshua GreenePhiladelphia$394K
- Alexander BruckerPhiladelphia$240K
- Tomas AlemanPhiladelphia$190K
- Benjamin KimPhiladelphia$177K
- Jay ChhablaniPittsburgh$70K
- Hugo LinaresPhiladelphia$38K
- Sachin PatelPottsville$17K
- Samuel JacobsonPhiladelphia$15K
- Brian VanderbeekPhiladelphia$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.